Cargando…
In vivo PET imaging of neuroinflammation in familial frontotemporal dementia
INTRODUCTION: We report in vivo patterns of neuroinflammation and abnormal protein aggregation in seven cases of familial frontotemporal dementia (FTD) with mutations in MAPT, GRN and C9orf72 genes. METHODS: Using positron emission tomography (PET), we explored the association of the distribution of...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892378/ https://www.ncbi.nlm.nih.gov/pubmed/33122395 http://dx.doi.org/10.1136/jnnp-2020-323698 |
_version_ | 1783652835990175744 |
---|---|
author | Malpetti, Maura Rittman, Timothy Jones, Peter Simon Cope, Thomas Edmund Passamonti, Luca Bevan-Jones, William Richard Patterson, Karalyn Fryer, Tim D Hong, Young T Aigbirhio, Franklin I O'Brien, John Tiernan Rowe, James Benedict |
author_facet | Malpetti, Maura Rittman, Timothy Jones, Peter Simon Cope, Thomas Edmund Passamonti, Luca Bevan-Jones, William Richard Patterson, Karalyn Fryer, Tim D Hong, Young T Aigbirhio, Franklin I O'Brien, John Tiernan Rowe, James Benedict |
author_sort | Malpetti, Maura |
collection | PubMed |
description | INTRODUCTION: We report in vivo patterns of neuroinflammation and abnormal protein aggregation in seven cases of familial frontotemporal dementia (FTD) with mutations in MAPT, GRN and C9orf72 genes. METHODS: Using positron emission tomography (PET), we explored the association of the distribution of activated microglia, as measured by the radioligand [(11)C]PK11195, and the regional distribution of tau or TDP-43 pathology, indexed using the radioligand [(18)F]AV-1451. The familial FTD PET data were compared with healthy controls. RESULTS: Patients with familial FTD across all mutation groups showed increased [(11)C]PK11195 binding predominantly in frontotemporal regions, with additional regions showing abnormalities in individuals. Patients with MAPT mutations had a consistent distribution of [(18)F]AV-1451 binding across the brain, with heterogeneous distributions among carriers of GRN and C9orf72 mutations. DISCUSSION: This case series suggests that neuroinflammation is part of the pathophysiology of familial FTD, warranting further consideration of immunomodulatory therapies for disease modification and prevention. |
format | Online Article Text |
id | pubmed-7892378 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-78923782021-03-03 In vivo PET imaging of neuroinflammation in familial frontotemporal dementia Malpetti, Maura Rittman, Timothy Jones, Peter Simon Cope, Thomas Edmund Passamonti, Luca Bevan-Jones, William Richard Patterson, Karalyn Fryer, Tim D Hong, Young T Aigbirhio, Franklin I O'Brien, John Tiernan Rowe, James Benedict J Neurol Neurosurg Psychiatry Neurodegeneration INTRODUCTION: We report in vivo patterns of neuroinflammation and abnormal protein aggregation in seven cases of familial frontotemporal dementia (FTD) with mutations in MAPT, GRN and C9orf72 genes. METHODS: Using positron emission tomography (PET), we explored the association of the distribution of activated microglia, as measured by the radioligand [(11)C]PK11195, and the regional distribution of tau or TDP-43 pathology, indexed using the radioligand [(18)F]AV-1451. The familial FTD PET data were compared with healthy controls. RESULTS: Patients with familial FTD across all mutation groups showed increased [(11)C]PK11195 binding predominantly in frontotemporal regions, with additional regions showing abnormalities in individuals. Patients with MAPT mutations had a consistent distribution of [(18)F]AV-1451 binding across the brain, with heterogeneous distributions among carriers of GRN and C9orf72 mutations. DISCUSSION: This case series suggests that neuroinflammation is part of the pathophysiology of familial FTD, warranting further consideration of immunomodulatory therapies for disease modification and prevention. BMJ Publishing Group 2021-03 2020-10-29 /pmc/articles/PMC7892378/ /pubmed/33122395 http://dx.doi.org/10.1136/jnnp-2020-323698 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Neurodegeneration Malpetti, Maura Rittman, Timothy Jones, Peter Simon Cope, Thomas Edmund Passamonti, Luca Bevan-Jones, William Richard Patterson, Karalyn Fryer, Tim D Hong, Young T Aigbirhio, Franklin I O'Brien, John Tiernan Rowe, James Benedict In vivo PET imaging of neuroinflammation in familial frontotemporal dementia |
title | In vivo PET imaging of neuroinflammation in familial frontotemporal dementia |
title_full | In vivo PET imaging of neuroinflammation in familial frontotemporal dementia |
title_fullStr | In vivo PET imaging of neuroinflammation in familial frontotemporal dementia |
title_full_unstemmed | In vivo PET imaging of neuroinflammation in familial frontotemporal dementia |
title_short | In vivo PET imaging of neuroinflammation in familial frontotemporal dementia |
title_sort | in vivo pet imaging of neuroinflammation in familial frontotemporal dementia |
topic | Neurodegeneration |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892378/ https://www.ncbi.nlm.nih.gov/pubmed/33122395 http://dx.doi.org/10.1136/jnnp-2020-323698 |
work_keys_str_mv | AT malpettimaura invivopetimagingofneuroinflammationinfamilialfrontotemporaldementia AT rittmantimothy invivopetimagingofneuroinflammationinfamilialfrontotemporaldementia AT jonespetersimon invivopetimagingofneuroinflammationinfamilialfrontotemporaldementia AT copethomasedmund invivopetimagingofneuroinflammationinfamilialfrontotemporaldementia AT passamontiluca invivopetimagingofneuroinflammationinfamilialfrontotemporaldementia AT bevanjoneswilliamrichard invivopetimagingofneuroinflammationinfamilialfrontotemporaldementia AT pattersonkaralyn invivopetimagingofneuroinflammationinfamilialfrontotemporaldementia AT fryertimd invivopetimagingofneuroinflammationinfamilialfrontotemporaldementia AT hongyoungt invivopetimagingofneuroinflammationinfamilialfrontotemporaldementia AT aigbirhiofranklini invivopetimagingofneuroinflammationinfamilialfrontotemporaldementia AT obrienjohntiernan invivopetimagingofneuroinflammationinfamilialfrontotemporaldementia AT rowejamesbenedict invivopetimagingofneuroinflammationinfamilialfrontotemporaldementia |